View More Recent Stories

Aug 30, 2021 06:30AM Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform
May 10, 2021 06:30AM Flagship Pioneering Unveils Laronde to Advance Endless RNA™ - A New Class of Programmable Medicines Capable of Expressing Therapeutic Proteins Inside the Body
View More Recent Stories